4T1-hHER2-Luc

Export PDF

Strain Information

Cell Line

4T1-Tg(hHER2-Luc)Smoc

Cat. NO.

NM-S07-TM04

Model Description

HER2 gene humanized 4T1 cell line

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Fig1. HER2 expression in 4T1-hHER2 cell lines.

image.png

Fig2. In vivo validation of 4T1-hHER2 in BALB/c mice.

BALB/c mice were inoculated with 4T1-hHER2 subcutaneously at 1×106 cells/mouse inoculum for tumor development.

image.png

Fig3. HER2 expression in tumors after in vivo growth of 4T1-hHER2 in wild type BALB/c mice.

The tumors were collected at day 34 post tumor cell inoculation.

Related Strain(s)

H22-Luc-hGPC3
Cell Line：

H22-Luc-hGPC3

Cat. NO.：NM-GA01-TM05
NCI-H929-Luc
Cell Line：

NCI-H929-Tg(luc)/Smoc

Cat. NO.：NM-GS03-1
MDA-MB-468-Luc
Cell Line：

MDA-MB-468-Luc

Cat. NO.：NM-R04-1
HCC1806-Luc
Cell Line：

HCC1806-Luc

Cat. NO.：NM-R11-1
HCC827-Luc
Cell Line：

HCC827-Luc

Cat. NO.：NM-F08-1

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more